Zobrazeno 1 - 10
of 684
pro vyhledávání: '"JOUENNE, F."'
Autor:
Louveau B; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Reger De Moura C; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Jouenne F; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Sadoux A; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Allayous C; Department of Dermatology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Da Meda L; Department of Dermatology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Bernard-Cacciarella M; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Baroudjian B; Department of Dermatology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Lebbé C; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Mourah S; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Dumaz N; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.
Publikováno v:
Melanoma research [Melanoma Res] 2024 Apr 01; Vol. 34 (2), pp. 186-192. Date of Electronic Publication: 2023 Dec 22.
Autor:
Louveau B; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immu-notherapy (HIPI), Paris, France., Jouenne F; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immu-notherapy (HIPI), Paris, France., Ram-Wolff C; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immu-notherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Mancini M; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., De Masson A; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immu-notherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Mourah S; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immu-notherapy (HIPI), Paris, France., Battistella M; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immu-notherapy (HIPI), Paris, France.; Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2024 Dec 13. Date of Electronic Publication: 2024 Dec 13.
Autor:
Reger De Moura C; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010, Paris, France., Louveau B; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010, Paris, France., Jouenne F; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010, Paris, France., Vilquin P; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France., Battistella M; Department of Pathology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France., Bellahsen-Harrar Y; Department of Pathology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France., Sadoux A; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France., Menashi S; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010, Paris, France., Dumaz N; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010, Paris, France., Lebbé C; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010, Paris, France.; Department of Dermatology and CIC, Hôpital Saint Louis, Cancer Institute, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France., Mourah S; Department of Pharmacology and Tumor Genomics, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France. samia.mourah@aphp.fr.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), F-75010, Paris, France. samia.mourah@aphp.fr.
Publikováno v:
Oncogene [Oncogene] 2024 May; Vol. 43 (21), pp. 1620-1630. Date of Electronic Publication: 2024 Apr 03.
Autor:
Kervarrec T; Department of Pathology, Centre Hospitalier Universitaire de Tours, Université de Tours, Tours, France.; 'Biologie des infections à polyomavirus' Team, UMR INRA ISP 1282, Université de Tours, Tours, France.; CARADERM Network., Westphal D; National Center for Tumour Diseases (NCT), Partner Site Dresden, Dresden, Germany.; Department of Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany., Pissaloux D; Department of Biopathology, Center Léon Bérard, Lyon, France.; Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer, Lyon, France., Legrand M; Department of Pathology, Centre Hospitalier Universitaire de Tours, Université de Tours, Tours, France., Tirode F; Department of Biopathology, Center Léon Bérard, Lyon, France.; Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer, Lyon, France., Neuhart A; Department of Biopathology, Center Léon Bérard, Lyon, France.; Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer, Lyon, France., Drouot F; CARADERM Network.; Department of Pathology, Cypath, Dijon, France., Becker JC; Department of Translational Skin Cancer Research, University Hospital Essen, Essen, Germany.; Department of Dermatology, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), Pa German Cancer Research Center (DKFZ), Heidelberg, Germany., Macagno N; CARADERM Network.; Department of Pathology, Timone University Hospital, Marseille, France., Seris A; CARADERM Network.; Service de Dermatologie, Centre hospitalier de Pau, Pau, France., Jouary T; CARADERM Network.; Service de Dermatologie, Centre hospitalier de Pau, Pau, France., Beltzung F; Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France., Jullie ML; CARADERM Network.; Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France., Harms PW; Department of Pathology, Michigan Medicine/University of Michigan, Ann Arbor, MI, USA.; Department of Dermatology, Michigan Medicine/University of Michigan, Ann Arbor, MI, USA., Cribier B; Dermatology Clinic, Hopitaux Universitaires & Université de Strasbourg, Hopital Civil, Strasbourg, France., Mourah S; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital, Paris University, AP-HP, Paris, France., Jouenne F; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital, Paris University, AP-HP, Paris, France., Fromont G; Department of Pathology, Centre Hospitalier Universitaire de Tours, Université de Tours, Tours, France., Louveau B; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital, Paris University, AP-HP, Paris, France., Mancini M; Department of Pharmacology and Solid Tumor Genomics, Saint Louis Hospital, Paris University, AP-HP, Paris, France., Kazakov DV; IDP Dermatohistopathologie Institut, Pathologie Institut Enge, Zurich, Switzerland., de la Fouchardière A; CARADERM Network.; National Center for Tumour Diseases (NCT), Partner Site Dresden, Dresden, Germany.; Department of Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany., Battistella M; CARADERM Network.; Department of Pathology, APHP Hôpital Saint Louis, INSERM U976, Université Paris Cité7, Paris, France.
Publikováno v:
Histopathology [Histopathology] 2024 Oct; Vol. 85 (4), pp. 566-578. Date of Electronic Publication: 2024 May 24.
Autor:
Louveau B; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Nakouri I; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Jouenne F; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Baroudjian B; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Sadoux A; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Da Meda L; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Osio A; Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; CND-Paris la Roquette, Ivry, France.; French Network of Rare Skin Cancers, CARADERM, France., Reinhart F; Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Robert J; DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Herms F; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Cribier B; French Network of Rare Skin Cancers, CARADERM, France.; Dermatology and Dermatopathology, Faculty of Medicine, University Hospital, University of Strasbourg, Strasbourg, France., Mortier L; French Network of Rare Skin Cancers, CARADERM, France.; Department of Dermatology, Claude Huriez Hospital and University of Lille, Lille, France., Jouary T; French Network of Rare Skin Cancers, CARADERM, France.; Department of Dermatology, Hospital Center of Pau, Pau, France., Basset Seguin N; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Lebbé C; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Mourah S; Department of Pharmacology and Tumor Genomics, DMU BioGeM, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France., Battistella M; Université Paris Cité, INSERM UMR-S 976, Team 1, Human Immunology Pathophysiology & Immunotherapy (HIPI), Paris, France.; Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.; French Network of Rare Skin Cancers, CARADERM, France.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2024 Sep 18; Vol. 191 (4), pp. 639-641.
Autor:
Barbieux S; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France; Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France. Electronic address: simon_barbieux@orange.fr., Jouenne F; Department of Tumors Genomics and Pharmacology, Hôpital Saint-Louis, AP-HP, Paris, France., Machet MC; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France., Fraitag S; Department of Pathology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France., Macagno N; Department of Pathology, Centre Hospitalier de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France; CARADERM Network, France., Battistella M; CARADERM Network, France; Department of Pathology, Hôpital Saint-Louis, AP-HP, Paris, France., Cribier B; CARADERM Network, France; Department of Dermatology, Hôpitaux Universitaires et Université de Strasbourg, Strasbourg, France., Sohier P; CARADERM Network, France; Department of Pathology, Hôpital Cochin, AP-HP, Centre-Université Paris Cité, Paris, France., Laurent-Roussel S; CARADERM Network, France; Department of Pathology, Hôpital Cochin, AP-HP, Centre-Université Paris Cité, Paris, France; National Center of Dermatopathology - La Roquette, Paris, France., Carlotti A; Department of Pathology, Hôpital Cochin, AP-HP, Centre-Université Paris Cité, Paris, France., Beltzung F; Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France., Jullié ML; CARADERM Network, France; Department of Pathology, Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France., Moulonguet I; Department of Pathology, Hôpital Saint-Louis, AP-HP, Paris, France., Basset-Seguin N; CARADERM Network, France; Department of Dermatology, Hôpital Saint-Louis, AP-HP, Paris, France., Deschamps L; CARADERM Network, France; Department of Pathology, Hôpital Bichat, AP-HP, Paris, France., Mourah S; Department of Tumors Genomics and Pharmacology, Hôpital Saint-Louis, AP-HP, Paris, France., Samimi M; CARADERM Network, France; Department of Dermatology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France; 'Biologie des infections à polyomavirus' Team, UMR INRA ISP 1282, Université de Tours, Tours, France., Guyétant S; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France; Platform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France; 'Biologie des infections à polyomavirus' Team, UMR INRA ISP 1282, Université de Tours, Tours, France., Kervarrec T; Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France; CARADERM Network, France; 'Biologie des infections à polyomavirus' Team, UMR INRA ISP 1282, Université de Tours, Tours, France.
Publikováno v:
Pathology [Pathology] 2024 Sep 17. Date of Electronic Publication: 2024 Sep 17.
Autor:
Jouenne F; Université Paris-Cité, INSERM U976, Human Immunology Pathophysiology and Immunotherapy (HIPI), Institut de Recherche Saint-Louis.; Department of Pharmacology and Genomics., Benattia A; National Reference Centre for Histiocytoses, Department of Pulmonology, AP-HP, Hôpital Saint-Louis, Paris, France., Tazi A; Université Paris-Cité, INSERM U976, Human Immunology Pathophysiology and Immunotherapy (HIPI), Institut de Recherche Saint-Louis.; National Reference Centre for Histiocytoses, Department of Pulmonology, AP-HP, Hôpital Saint-Louis, Paris, France.
Publikováno v:
Current opinion in pulmonary medicine [Curr Opin Pulm Med] 2023 Sep 01; Vol. 29 (5), pp. 451-458. Date of Electronic Publication: 2023 Jul 06.
Autor:
Louveau, B., Jouenne, F., Sadoux, A., Mancini, M., Reger de Moura, C., Baroudjian, B., Da Meda, L., Brayet, J., Vilquin, P., Lebbé, C., Battistella, M., Mourah, S.
Publikováno v:
In EJC Skin Cancer 2024 2 Supplement 1
Autor:
Louveau, B., Nakouri, I., Jouenne, F., Baroudjian, B., Sadoux, A., Da Meda, L., Osio, A., Reinhart, F., Robert, J., Mancini, M., Herms, F., Cribier, B., Mortier, L., Jouary, T., Basset-Seguin, N., Lebbé, C., Mourah, S., Battistella, M.
Publikováno v:
In EJC Skin Cancer 2024 2 Supplement 1
Autor:
Reger de Moura, C., Louveau, B., Jouenne, F., Vilquin, P., Battistella, M., Bellahsen, Y., Sadoux, A., Menashi, S., Mancini, M., Dumaz, N., Lebbé, C., Mourah, S.
Publikováno v:
In EJC Skin Cancer 2024 2 Supplement 1